MedTrace Logo

Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis

NCT02873273 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-10-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether a longer duration, controlled, sustained release dexamethasone delivery system would be more effective in helping patients with osteoarthritis reduce their pain, remain functional, and delay their need for knee replacement.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Dexamethasone

Sustained delivery system containing 5.0 mg of dexamethasone programmed to release an estimated 10 μg per day

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    collaborator OTHER

  • Mark Figgie

    lead OTHER

Principal Investigators

  • Mark Figgie, MD · Hospital for Special Surgery, New York

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-14
Primary Completion
2017-09-21
Completion
2017-09-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873273 on ClinicalTrials.gov